AOR COMMISSIONED RESEARCH: Use of Opioid Recovery Medications and Payment types by State, IMS Institute for Healthcare Informatics

Quintiles IMS Institute reviewed retail data from long-term opioid recovery medication buprenorphine. The findings showed huge variance in who pays in each state and the rate of growth declining. The summary conclusion: Patient access to – and reimbursement for – buprenorphine medications used in addiction recovery programs varies widely across states and suggests inconsistent and suboptimal approaches in many parts of the country.”

Read the report.

Share This Post